None listed
Conditions
Interventions
Intervention1: Single visit 4 site Pre-Exposure Prophylaxis.: This group will receive single visit 4 dose of anti-rabies vaccine at a dose of 0.1ml on each deltoid and each supraclavicular region.
Co
Sponsors
AMAN DEV SINGH
Rohit Batish
Eligibility
Inclusion criteria
Inclusion criteria: Immunologically naive healthy human volunteers who have never received anti-rabies treatment in the past and are willing to give verbal consent will be included in study.
Exclusion criteria
Exclusion criteria: Those who have received anti-rabies treatment in the past whether complete or incomplete will be excluded from study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| analysis of rabies antibody Titre on day 28th by ELISA method for in both groups and comparison of differences in antibody titre if any.Timepoint: analysis of rabies antibody Titre on day 28th by ELISA method for in both groups and comparison of differences in antibody titre if any. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactAMAN DEV SINGH
Government Medical College and Rajindra Hospital Patiala
Outcome results
None listed